Cargando…
Inhibition of PI3K-AKT Signaling Blocks PGE(2)-Induced COX-2 Expression in Lung Adenocarcinoma
PURPOSE: Cyclooxygenase-2 (COX-2) and its enzymatic product prostaglandin E2 (PGE(2)) possess tumor-promoting activity, and COX-2 is considered as a candidate for targeted cancer therapy. However, several randomized clinical trials using COX-2 inhibitors to treat advanced lung cancer have failed to...
Autores principales: | Yang, Jianjian, Wang, Xue, Gao, Yi, Fang, Can, Ye, Fan, Huang, Bing, Li, Lequn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455753/ https://www.ncbi.nlm.nih.gov/pubmed/32904445 http://dx.doi.org/10.2147/OTT.S263977 |
Ejemplares similares
-
COX-2-PGE(2)-EPs in gynecological cancers
por: Ye, Yao, et al.
Publicado: (2020) -
Compound Wumei Powder Inhibits the Invasion and Metastasis of Gastric Cancer via Cox-2/PGE2-PI3K/AKT/GSK3β/β-Catenin Signaling Pathway
por: Ma, Nai-Xia, et al.
Publicado: (2017) -
Regulation of Matrix Metalloproteinase-2 Activity by COX-2-PGE2-pAKT Axis Promotes Angiogenesis in Endometriosis
por: Jana, Sayantan, et al.
Publicado: (2016) -
Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE(2) expression
por: Wang, Huiqiang, et al.
Publicado: (2015) -
Improving VEGF-targeted therapies through inhibition of COX-2/PGE(2) signaling
por: Xu, Lihong, et al.
Publicado: (2014)